Valiant Organics Limited has informed the Exchange about Investor Presentation
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Organics, a specialty chemicals maker (chlorophenol derivatives, PNA, dyes & pigments intermediates) with 6 plants and 70,000 TPA capacity, has filed its AGM investor presentation with the exchanges. FY25 operating revenue stood at ₹719 Cr (flat vs ₹723 Cr in FY24, but well below the ₹1,153 Cr peak in FY22 due to the deconsolidation of step-down subsidiary Valiant Laboratories from Oct 2023). EBITDA rose to ₹54 Cr from ₹38 Cr, lifting margins to 7.47% from 5.28%. However, the company remained in the red at the bottom line with a PAT loss of ₹3 Cr (vs ₹8 Cr loss in FY24). Net debt/equity is a comfortable 0.33x and net worth is ₹570 Cr, while ROCE was a weak 2.72%. Revenue mix is dominated by Dyes & Pigments (52%) and Agro Chemicals (25%).
The presentation offers no fresh forward-looking guidance – it largely recaps FY25 results and the company's product/plant profile. For shareholders, the takeaway is that operating margins are recovering modestly but profitability and returns remain under pressure, so this is an informational filing with limited near-term stock catalyst unless management signals emerge in the AGM Q&A.